AN2 Therapeutics, Inc.
NASDAQANTX short interest surges 26% in one week to 3.1% of float, driven by 7% single-day jump. Cost to borrow falls to 2.66%, down 27% weekly. Earnings report due May 20.
Snapshot as of 25 Jun 2026
ANTX enters its May 13 earnings event riding an extraordinary one-month surge. The stock has climbed nearly 59% to $4.72 over the past month — a move that dramatically outpaces its small-cap biotech peers and sets a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANTX — free to start on ORTEX.
Sign up for free →Open ANTX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live ANTX data →